ANGEL Robotics is a pioneering company in the field of Robotics, with a vision to recreate human abilities through innovative technology. The company, founded in 2014 in South Korea, focuses on the development of wearable robotic devices by combining expertise from the disciplines of engineering and medicine. Their commitment to research and development is underscored by a recent KRW18.00B Series B investment on 29 September 2021.
The significant investment comes as a result of the company's collaborative efforts in the realm of robotics and clinical technology, aiming to commercialize cutting-edge solutions for rehabilitation and human augmentation. The notable investors involved in this funding round include K2 Investment Partners, Albatross Investment, Maple Investment Partners, SGI Venture Capital, Hyundai Technology Investment, and Soo Investment Capital.
Angel Robotics' mission extends beyond commercial success, as it aspires to generate societal value and contribute to the realization of universal happiness. Their ongoing research and clinical trials reflect a commitment to leveraging technology for the betterment of society and human well-being. With a strong foundation and a clear vision, Angel Robotics is poised to make a significant impact in the robotics industry.